Recurrent Ovarian Low Grade Serous Adenocarcinoma
3 clinical trials · Condition
◉ Watch Recurrent Ovarian Low Grade Serous Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents (NCT04739800) | National Cancer Institute (NCI) | 2021-06-10 |
| A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer (NCT04092270) | National Cancer Institute (NCI) | 2020-05-07 |
| Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer (NCT02101788) | National Cancer Institute (NCI) | 2014-04-11 |
Track Recurrent Ovarian Low Grade Serous Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.